Letter: Hepatitis B and MAFLD - a consilience of risk factors for hepatocellular carcinoma

被引：2
|
作者：
Zheng, Kenneth I. [1 ]
Zheng, Ming-Hua [1 ,2 ,3 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[3] Key Lab Diag & Treatment Dev Chron Liver Dis Zhej, Wenzhou, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 54卷 / 05期
基金：
中国国家自然科学基金;
关键词：
CIRRHOSIS;
D O I：
10.1111/apt.16532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Estes et al paper. To view this article, visit
引用
收藏
页码：736 / 737
页数：2
相关论文
共 50 条
  • [1] Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Huang, Rui
    Liu, Jiacheng
    Wang, Jian
    Yan, Xiaomin
    Wu, Chao
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (06) : 761 - 762
  • [2] Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma
    Chen, Y. C.
    Liaw, Y. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (02) : 210 - 211
  • [3] Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Jiang, J. -F.
    Sun, J.
    Shi, J.
    Liu, X.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (09) : 1286 - 1288
  • [4] Hepatitis B virus genotype and mutants: Risk factors for hepatocellular carcinoma
    Llovet, Josep M.
    Lok, Anna
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (16): : 1121 - 1123
  • [5] Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C
    Walter, Scott R.
    Thein, Hla-Hla
    Gidding, Heather F.
    Amin, Janaki
    Law, Matthew G.
    George, Jacob
    Dore, Gregory J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (12) : 1757 - 1764
  • [6] Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuan-Qing
    Peng, Li-Jun
    Cao, Yi-Rong
    Zeng, Zhi-Ping
    Wu, Yu-Jing
    Shi, Hong
    Cheng, Shi-Yao
    Wang, Ji-Yao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jin-Sheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 535 - 543
  • [7] Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma
    Pandyarajan, Vijay
    Govalan, Rajalakshmi
    Yang, Ju Dong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (02) : 1 - 19
  • [8] Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B
    Gattani, Mayur
    Ingle, Meghraj
    Chauhan, Shamshersingh
    Lad, Saiprasad
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 911 - 912
  • [9] Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Huang, Rui
    Wang, Jian
    Wu, Weihua
    Yan, Xiaomin
    Wu, Chao
    HEPATOLOGY, 2020, 71 (06) : 2173 - 2174
  • [10] Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B
    Seo, Seung In
    Kim, Hyoung Su
    Yang, Bo Kyung
    Kang, Jin Gu
    Shin, Woon Geon
    Lee, Jin Heon
    Kim, Hak Yang
    Jang, Myoung Kuk
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (05) : 711 - 717
12345